SEC Form 4 · accession 0001062993-19-001160
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis Bedoret
Officer — See Remarks
Period of report
May 14, 2018
Accepted (ET)
Mar 5, 2019 · 6:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $8.43 | May 14, 2018 | A | 15,000 | A | — | May 14, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a two-year period, beginning on June 30, 2018.
Remarks
Title: General Manager of MaSTherCell, S.A., subsidiary of Orgenesis Inc.